Phase II trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 125, doi. 10.3892/mco.2015.571
- By:
- Publication type:
- Article